Evidence map›Paper›PMID 39587553›Full record

ArticleBMC pregnancy and childbirth2024

A novel approach for the early prediction and prevention of placenta accreta spectrum and severe peripartum hemorrhage in patients with complete placenta previa: leveraging three-dimensional placental topography, cervical length, and dilatation parameters on magnetic resonance imaging.

Sadık Kükrer, Sefa Arlıer, Okan Dilek, Çağrı Gülümser

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sadık KükrerDepartment of Obstetrics and Gynecology, University of Health Sciences Adana City Training and Research Hospital, Mithat Özsan Bulvarı Kışla Mah. 4522 Sok. No:1, Adana, Turkey, Adana, Turkey. sadikkukrer01@gmail.com.ORCID http://orcid.org/0000-0001-8465-3225
Sefa ArlıerDepartment of Obstetrics and Gynecology, University of Health Sciences Adana City Training and Research Hospital, Mithat Özsan Bulvarı Kışla Mah. 4522 Sok. No:1, Adana, Turkey, Adana, Turkey.ORCID http://orcid.org/0000-0002-0019-8403
Okan DilekDepartment of Radiology, University of Health Sciences Adana City Training and Research Hospital, Mithat Özsan Bulvarı Kışla Mah. 4522 Sok. No:1, Adana, Turkey, Adana, Turkey.ORCID http://orcid.org/0000-0002-2144-2460
Çağrı GülümserDepartment of Obstetrics and Gynecology, Yuksek Ihtisas University, İşçi Blokları Mahallesi 1505. Cd. No: 18/A, Çankaya, Ankara, 06530, Turkey.ORCID http://orcid.org/0000-0002-4066-9038

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the reliability of placental volume and other magnetic resonance imaging (MRI) markers for predicting placenta accreta spectrum and severe peripartum hemorrhage in patients with complete placenta previa.

methodsThis single-center retrospective cohort study was conducted at a tertiary care facility and included 216 pregnant women diagnosed with complete placenta previa. Two radiologists, blinded to each other's assessments, independently evaluated the prenatal placental magnetic resonance imaging (pMRI) findings of 150 singleton pregnancies that met the inclusion criteria and were delivered in the third trimester. The three-dimensional placental volume (from the S1 and S2 sectors), cervical canal length (CCL), and degree of cervical canal dilatation (CCD) were compared with clinical and pathological findings. Univariate and multivariate logistic regression analyses identified risk factors for placenta accreta spectrum (PAS) and severe peripartum hemorrhage (SPPH). Receiver operating characteristic (ROC) curve analysis determined the cutoff values of significant predictors.

resultsUnivariate analysis revealed significant risk factors for PAS, including decreased cervical canal length (odds ratio [OR] = 1.330, p < 0.001), increased cervical canal dilation (OR = 1.869, p < 0.001), decreased S1 volume (OR = 1.008, p < 0.001), and increased S2 volume (OR = 1.008, p < 0.001). Multivariate analysis confirmed that cervical canal length was an independent risk factor (odds ratio [OR] = 1.253, p = 0.03). Significant predictors of severe peripartum hemorrhage included decreased cervical canal length (odds ratio [OR] = 0.406, p = 0.006), increased cervical canal dilatation (OR = 3.22, p < 0.001), decreased S1 volume (OR = 1.079, p = 0.017), and increased S2 volume (OR = 1.032, p < 0.001), all of which were confirmed as independent risk factors. ROC analysis demonstrated high precision for MRI markers, with area under the curve values above 0.8 for critical predictors of PAS and severe peripartum hemorrhage, confirming their reliability (all p < 0.001).

conclusionThis study emphasizes the pivotal role of three-dimensional placental volume measurements in the S1 and S2 sectors, along with cervical canal length and dilation, in predicting PAS and severe peripartum hemorrhage in patients with complete placenta previa. Integrating these advanced MRI markers into prenatal care can enhance early detection, improve clinical decision-making, and ultimately improve maternal and fetal outcomes.

Indexed as

Magnetic Resonance ImagingPlacentaPlacenta AccretaPlacenta PreviaPostpartum HemorrhageAdultCervical Length MeasurementCervix UteriFemaleHumansImaging, Three-DimensionalPredictive Value of TestsPregnancyPregnancy Trimester, ThirdReproducibility of ResultsRetrospective StudiesCervical dilatationCervical length measurementMagnetic resonance imagingPlacenta accreta spectrumPlacenta previaSurgical hemorrhage

Identifiers

PMID39587553
PMCPMC11587741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.